
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.11 | 1.34 | 0.23 |
Shares | 98.89 | 98.89 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.67 | 20.12 |
Price to Book | 4.14 | 3.96 |
Price to Sales | 1.90 | 2.37 |
Price to Cash Flow | 17.67 | 15.98 |
Dividend Yield | 1.25 | 1.39 |
5 Years Earnings Growth | 11.50 | 11.54 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 98.80 | 94.34 |
Industrials | 1.20 | 3.25 |
Number of long holdings: 50
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 734.57 | -2.25% | |
Merck&Co | US58933Y1055 | 4.98 | 75.97 | -2.16% | |
Thermo Fisher Scientific | US8835561023 | 4.98 | 403.13 | -1.86% | |
UnitedHealth | US91324P1021 | 4.87 | 380.64 | -1.27% | |
Novo Nordisk B | DK0062498333 | 4.83 | 444.3 | +3.59% | |
AstraZeneca | GB0009895292 | 4.53 | 10,240.0 | +1.05% | |
Becton Dickinson | US0758871091 | 4.37 | 167.22 | -0.43% | |
Intuitive Surgical | US46120E6023 | 3.70 | 536.51 | -0.31% | |
DexCom | US2521311074 | 3.43 | 84.67 | -0.79% | |
Boston Scientific | US1011371077 | 2.79 | 102.86 | -0.42% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 1.08B | -16.31 | 1.50 | 15.56 | ||
AXA Framlington Global Technology F | 1.08B | -16.30 | 1.50 | 15.56 | ||
GB00B5LXGG05 | 1.02B | -13.31 | 8.03 | 14.25 | ||
AXA Framlington Managed Income Funa | 262.87M | 1.65 | 3.42 | 3.88 | ||
AXA Framlington Managed Income Funr | 262.87M | 1.64 | 3.39 | 3.75 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review